These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 420220)

  • 21. The preparation and use of a formulary in a provincial hospital.
    Baker P
    Med J Zambia; 1979; 13(5):96-7. PubMed ID: 263384
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacy U.R. cuts costs, drug use.
    Mosier RL
    Hosp Peer Rev; 1979 May; 4(5):70-2. PubMed ID: 10308905
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Criteria-based DUE aids in selection of preferred agent.
    Drea EJ
    Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing the number of formulary theophylline preparations.
    Anandan JV
    Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An approach to regulating cephalosporin use and costs.
    Ryan JL; Francese J
    Hosp Formul; 1980 Sep; 15(9):674-6. PubMed ID: 10248357
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of an enteral products formulary.
    Durfee DD; Skinner-Domet VM
    Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoeconomic analysis in formulary decisions: an international perspective.
    Johnson JA; Bootman JL
    Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P&T Committee guidelines for antibiotic cost comparisons.
    McCue JD
    Hosp Formul; 1986 Jun; 21(6):703-6. PubMed ID: 10276798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term value of the selected list as a method of controlling drug costs in a district general hospital.
    Upton DR; Holmes GK; Fox PD; Cullen AM; Poston JW
    Health Trends; 1989 Feb; 21(1):26-9. PubMed ID: 10292126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of seasonal allergic rhinitis: cost implications of pharmacotherapy for managed care.
    Trotter JP
    Manag Care Interface; 2000 Jan; 13(1):60-2. PubMed ID: 10747693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of formulary inclusion costs.
    Myers CE; Pierpaoli P; Smith MA
    Hosp Formul; 1981 Sep; 16(9):951-3, 957-8, 967-8 passim. PubMed ID: 10252372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.